These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

57 related items for PubMed ID: 4079594

  • 1. Pharmacokinetics of intravenous propafenone in patients with episodes of paroxysmal supraventricular tachycardia.
    Arboix M, Puigdemont A, Moya A, Cinca J.
    Methods Find Exp Clin Pharmacol; 1985 Aug; 7(8):435-8. PubMed ID: 4079594
    [Abstract] [Full Text] [Related]

  • 2. [Electrophysiological effects of intravenous and oral propafenone in patients with supraventricular paroxysmal tachycardias: correlation with drug blood levels].
    Moya A, Cinca J, Arboix M, Rius J.
    Rev Esp Cardiol; 1985 Aug; 38(3):198-202. PubMed ID: 4012004
    [No Abstract] [Full Text] [Related]

  • 3. Paroxysmal supraventricular tachycardia: experience with propafenone.
    Santinelli V, De Paola M, Turco P, Smimmo D, Chiariello M.
    Angiology; 1989 Jun; 40(6):563-8. PubMed ID: 2719341
    [Abstract] [Full Text] [Related]

  • 4. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.
    Circulation; 1995 Nov 01; 92(9):2550-7. PubMed ID: 7586356
    [Abstract] [Full Text] [Related]

  • 5. Investigations on the pharmacokinetics of propafenone in man.
    Hollmann M, Brode E, Hotz D, Kaumeier S, Kehrhahn OH.
    Arzneimittelforschung; 1983 Nov 01; 33(5):763-70. PubMed ID: 6683556
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P, Leclercq JF, Assayag P, Maisonblanche P, Cauchemez B.
    Arch Mal Coeur Vaiss; 1984 Nov 01; 77(12):1370-82. PubMed ID: 6439161
    [Abstract] [Full Text] [Related]

  • 12. [Clinical pharmacology of propafenone].
    Ambrosioni E, Marchesini B.
    G Ital Cardiol; 1984 Apr 01; 14(4):285-92. PubMed ID: 6735021
    [Abstract] [Full Text] [Related]

  • 13. [Effect of intravenous propafenone on maintenance of atrial signal-averaged ECG in patients with paroxysmal atrial fibrillation].
    Banasiak W, Zebrowski J, Wiech K, Telichowski A, Kokot K, Zapałowicz R, Pieróg M, Lacheta W, Telichowski C.
    Pol Tyg Lek; 1996 Mar 01; 51(10-13):141-4. PubMed ID: 8927547
    [Abstract] [Full Text] [Related]

  • 14. [Efficacy and safety of adenosine triphosphate in the control of supraventricular paroxysmal tachycardia].
    Brandão L, de Sousa J, Barreiros MC, Vagueiro MC, Amram SS.
    Rev Port Cardiol; 1994 Mar 01; 13(3):197-202, 191. PubMed ID: 8049086
    [Abstract] [Full Text] [Related]

  • 15. [Sustained ventricular tachycardia: induced polymorphism. Clinical and electrophysiological aspects; therapeutic implications].
    Vergara G, Disertori M, Inama G, Guarnerio M, Bettini R, Durante G, Stirpe E, Furlanello F.
    G Ital Cardiol; 1984 Dec 01; 14(12):972-81. PubMed ID: 6532893
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.